Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To determine if a subcutaneous dosing schedule of veltuzumab can be established in NHL or CLL paitent and to confirm safety and efficacy of veltuzumab that was previously established when administered intravenously.
Inclusion criteria
- Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia